Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology


Weeks in Review


Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

In Vitro Activities of Cefatrizine/clavulanic Acid Against Major Clinical Isolates of Bacteria

Original article

Annals of Clinical Microbiology (Ann Clin Microbiol) 1999 December Volume 2, Issue 2, pages 182-193.

In Vitro Activities of Cefatrizine/clavulanic Acid Against Major Clinical Isolates of Bacteria

Jae Lim Chung, M.D., Young Ah Kim, M.D., Hee Bong Shin, M.D., Jeong Won Shin, M.D., Kyungwon Lee, M.D., Yunsop Chong, Ph.D., Jang Hyeon Park, Ph.D.* and Won Bae Kim, Ph.D.*

Department of Clinical Pathology and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Research Laboratories, Dong-A Pharm. Co., Ltd., Yongin, Kyunggi-do, Korea*


Background: β-lactam antibiotics are one of the most frequently used antimicrobial agents. However, with the increase of β-lactamase-producing bacteria, penicillins and 1st generation cephalosporins have become less useful. Cefatrizine and clavulanic acid combination (CTCA) was developed to restore the activity. The aim of this study was to determine the activities of CTCA against major recent clinical isolates.

Methods: Aerobic and anaerobic bacteria tested were isolated from clinical specimens in Severance Hospital during 1996 to 1999. Antimicrobial susceptibility was determined by the NCCLS agar dilution methods.

Results: MICs of cefatrizine (CT) and CTCA were similar for methicillin-susceptible Staphylococcus aureus, Streptococcus pyogenes and S. pneumoniae. For Moraxella (Branhamella) catarrhalis, MIC90 of CTCA was 1 µg/mL, which was 1/8-fold lower than that of cefatrizine. MIC90s of CTCA for Escherichia coli and Klebsiella pneumoniae were 4 µg/mL and 8 µg/mL, respectively, which were 1/4- to 1/16-fold lower than those of CT. However, it was less active against Citrobacter freundii, Enterobacter cloacae and Serratia marcescens. Against Bacteroides fragilis group organisms, it showed good activities similar to those of other β-lactam and β-lactamase inhibitor combinations.

Conclusions: CTCA showed good antimicrobial activities against M. (B.) catarrhalis, Haemophilus influenzae, Neisseria gonorrhoeae, extended spectrum β-lactamase-producing E. coli and K. pneumoniae, Proteus vulgaris and B. fragilis. In conclusion, it would be useful for the treatment of infections due to those organisms, and for the empirical treatment of respiratory and urinary tract infections. (Korean J Clin Microbiol 1999;2:182-193)


Cefatrizine, Cefatrizine/clavulanic Acid, Antimicrobial activity, Bacteria, In vitro